Showing 1 - 10 of 36
Abstract Background Causal mediation analysis can improve understanding of the mechanisms underlying epidemiologic associations. However, the utility of natural direct and indirect effect estimation has been limited by the assumption of no confounder of the mediator-outcome relationship that is...
Persistent link: https://www.econbiz.de/10014590633
Persistent link: https://www.econbiz.de/10003375811
Persistent link: https://www.econbiz.de/10003942699
Persistent link: https://www.econbiz.de/10009657313
When compared against capecitabine alone, the addition of lapatinib has a cost-effectiveness ratio exceeding the threshold normally used by NICE. Compared with T + C, L + C is dominant in the base case and approximately equally likely to be cost-effective in probabilistic sensitivity...
Persistent link: https://www.econbiz.de/10010993884
Persistent link: https://www.econbiz.de/10009404192
Background: Deferasirox is a recently approved once-daily oral iron chelator that has been shown to reduce liver iron concentrations and serum ferritin levels to a similar extent as infusional deferoxamine. Objective: To determine the cost effectiveness of deferasirox versus deferoxamine in...
Persistent link: https://www.econbiz.de/10005449228
Persistent link: https://www.econbiz.de/10012097281
Abstract Young, Hernán, and Robins consider the mean outcome under a dynamic intervention that may rely on the natural value of treatment. They first identify this value with a statistical target parameter, and then show that this statistical target parameter can also be identified with a...
Persistent link: https://www.econbiz.de/10014590603
Abstract In conducting studies on an exposure of interest, a systematic roadmap should be applied for translating causal questions into statistical analyses and interpreting the results. In this paper we describe an application of one such roadmap applied to estimating the joint effect of both...
Persistent link: https://www.econbiz.de/10014590626